{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:43:53Z","timestamp":1780551833472,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1245\/s10434-024-16857-7","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T18:07:09Z","timestamp":1736964429000},"page":"2526-2533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patients with DCIS Seen at a Specialized High-Risk Breast Clinic Run by Surgical Advanced Practice Providers Have High Rates of Preventive Medication Uptake"],"prefix":"10.1245","volume":"32","author":[{"given":"Kathryn","family":"Paschalis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Regis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gooch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Dombrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Yirinec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Huston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"16857_CR1","unstructured":"Tomlinson-Hansen SE, Khan M, Cassaro S (2024) Breast ductal carcinoma in situ. 2023 Feb 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; PMID: 33620843"},{"issue":"4","key":"16857_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","volume":"121","author":"M van Seijen","year":"2019","unstructured":"van Seijen M, Lips EH, Thompson AM, Nik-Zainal S, Futreal A, Hwang ES, Verschuur E, Lane J, Jonkers J, Rea DW, Wesseling J. Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer. 2019;121(4):285\u201392. https:\/\/doi.org\/10.1038\/s41416-019-0478-6.","journal-title":"Br J Cancer"},{"issue":"18","key":"16857_CR3","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 Study. J Natl Cancer Inst. 1998;90(18):1371\u201388.","journal-title":"J Natl Cancer Inst"},{"key":"16857_CR4","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2015.35.e50","author":"KD Crew","year":"2015","unstructured":"Crew KD. Addressing barriers to uptake of breast cancer chemoprevention for patients and providers. Am Soc Clin Oncol Edu Book. 2015. https:\/\/doi.org\/10.14694\/EdBook_AM.2015.35.e50.","journal-title":"Am Soc Clin Oncol Edu Book"},{"issue":"23","key":"16857_CR5","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","volume":"295","author":"VG Vogel","year":"2006","unstructured":"Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. Jama. 2006;295(23):2727\u201341.","journal-title":"Jama"},{"issue":"10218","key":"16857_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(19)32955-1","volume":"395","author":"J Cuzick","year":"2020","unstructured":"Cuzick J, Sestak I, Forbes JF, Dowsett M, Cawthorn S, Mansel RE, Loibl S, Bonanni B, Evans DG, Howell A. Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial. The lancet. 2020;395(10218):117\u201322.","journal-title":"The lancet"},{"issue":"9169","key":"16857_CR7","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","volume":"353","author":"B Fisher","year":"1999","unstructured":"Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, Smith R, Begovic M, Dimitrov NV, Margolese RG, Kardinal CG, Kavanah MT, Fehrenbacher L, Oishi RH. Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial. Lancet. 1999;353(9169):1993\u20132000.","journal-title":"Lancet"},{"issue":"4","key":"16857_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/tbj.12418","volume":"21","author":"LL Reimers","year":"2015","unstructured":"Reimers LL, Sivasubramanian PS, Hershman D, Terry MB, Greenlee H, Campbell J, Kalinsky K, Maurer M, Jayasena R, Sandoval R, Alvarez M. Breast cancer chemoprevention among high-risk women and those with ductal carcinoma in situ. Breast J. 2015;21(4):377\u201386.","journal-title":"Breast J"},{"issue":"17","key":"16857_CR9","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1200\/JCO.22.02900","volume":"41","author":"M Lazzeroni","year":"2023","unstructured":"Lazzeroni M, Puntoni M, Guerrieri-Gonzaga A, Serrano D, Boni L, Buttiron Webber T, Fava M, Briata IM, Giordano L, Digennaro M, Cortesi L, Falcini F, Serra P, Avino F, Millo F, Cagossi K, Gallerani E, De Simone A, Cariello A, Aprile G, Renne M, Bonanni B, DeCensi A. Randomized placebo controlled trial of low-dose tamoxifen to prevent recurrence in breast noninvasive neoplasia: a 10-year follow-up of TAM-01 study. J Clin Oncol. 2023;41(17):3116\u201321.","journal-title":"J Clin Oncol"},{"issue":"2","key":"16857_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10549-022-06577-5","volume":"193","author":"B Bychkovsky","year":"2022","unstructured":"Bychkovsky B, Laws A, Katlin F, Hans M, Knust Graichen M, Pace LE, Scheib R, Garber JE, King TA. Initiation and tolerance of chemoprevention among women with high-risk Breast lesions: the potential of low-dose tamoxifen. Breast Cancer Res Treat. 2022;193(2):417\u201327.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"16857_CR11","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1016\/j.clbc.2019.08.002","volume":"20","author":"B Cutuli","year":"2020","unstructured":"Cutuli B, Lemanski C, De Lafontan B, Chauvet MP, De Lara CT, Mege A, Fric D, Richard-Molard M, Mazouni C, Cuvier C, Carre A, Kirova Y. Ductal carcinoma in situ: a French national survey. Analysis of 2125 patients. Clin Breast Cancer. 2020;20(2):e164\u201372. https:\/\/doi.org\/10.1016\/j.clbc.2019.08.002.","journal-title":"Clin Breast Cancer"},{"issue":"5","key":"16857_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1634\/theoncologist.2016-0397","volume":"22","author":"C Anderson","year":"2017","unstructured":"Anderson C, Meyer AM, Wheeler SB, Zhou L, Reeder-Hayes KE, Nichols HB. Endocrine therapy initiation and medical oncologist utilization among women diagnosed with ductal carcinoma in situ. Oncologist. 2017;22(5):535\u201341.","journal-title":"Oncologist"},{"key":"16857_CR13","first-page":"6091709","volume":"2017","author":"C Anderson","year":"2017","unstructured":"Anderson C, Winn AN, Dusetzina SB, Nichols HB. Endocrine therapy initiation among older women with ductal carcinoma in situ. J Cancer Epidemiol. 2017;2017:6091709.","journal-title":"J Cancer Epidemiol"},{"issue":"7","key":"16857_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1158\/1940-6207.CAPR-17-0029","volume":"10","author":"LC Karavites","year":"2017","unstructured":"Karavites LC, Kane AK, Zaveri S, Xu Y, Helenowski I, Hansen N, Bethke KP, Rasmussen-Torvik LJ, Khan SA. Tamoxifen acceptance and adherence among patients with ductal carcinoma in situ (DCIS) treated in a multidisciplinary setting. Cancer Prev Res (Phila). 2017;10(7):389\u201397.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"10","key":"16857_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJMoa040587","volume":"351","author":"KS Hughes","year":"2004","unstructured":"Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, Wheeler J, Champion LA, Smith TJ, Smith BL, Shapiro C, Muss HB, Winer E, Hudis C, Wood W, Sugarbaker D, Henderson IC, Norton L. Cancer and Leukemia group b; radiation therapy oncology group; eastern cooperative oncology group lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351(10):971\u20137.","journal-title":"N Engl J Med"},{"issue":"7","key":"16857_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2207586","volume":"388","author":"IH Kunkler","year":"2023","unstructured":"Kunkler IH, Williams LJ, Jack WJL, Cameron DA, Dixon JM. Breast-conserving surgery with or without irradiation in early breast cancer. N Engl J Med. 2023;388(7):585\u201394.","journal-title":"N Engl J Med"},{"issue":"7","key":"16857_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1056\/NEJMoa2302344","volume":"389","author":"TJ Whelan","year":"2023","unstructured":"Whelan TJ, Smith S, Parpia S, Fyles AW, Bane A, Liu FF, Rakovitch E, Chang L, Stevens C, Bowen J, Provencher S, Th\u00e9berge V, Mulligan AM, Kos Z, Akra MA, David Voduc K, Hijal T, Dayes IS, Pond G, Wright JR, Nielsen TO, Levine MN. Omitting radiotherapy after breast-conserving surgery in luminal a breast cancer. New Engl J Med. 2023;389(7):612\u20139. https:\/\/doi.org\/10.1056\/NEJMoa2302344.","journal-title":"New Engl J Med"},{"issue":"4","key":"16857_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1200\/JCO.23.02270","volume":"42","author":"R Jagsi","year":"2024","unstructured":"Jagsi R, Griffith KA, Harris EE, Wright JL, Recht A, Taghian AG, Lee L, Moran MS, Small W Jr, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell SN, Sharp J, Sabel M, Schott A, El-Tamer M. Omission of radiotherapy after breast-conserving surgery for women with breast cancer with low clinical and genomic risk: 5-year outcomes of IDEA. J Clin Oncol. 2024;42(4):390\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"16857_CR19","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10549-020-05908-8","volume":"184","author":"MO Meneveau","year":"2020","unstructured":"Meneveau MO, Keim-Malpass J, Camacho TF, Anderson RT, Showalter SL. Predicting adjuvant endocrine therapy initiation and adherence among older women with early-stage breast cancer. Breast Cancer Res Treat. 2020;184(3):805\u201316.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"16857_CR20","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamasurg.2023.5113","volume":"158","author":"SA Khan","year":"2023","unstructured":"Khan SA, Mi X, Xu Y, et al. Presurgical oral tamoxifen vs transdermal 4-hydroxytamoxifen in women with ductal carcinoma in situ: a randomized clinical trial. JAMA Surg. 2023;158(12):1265\u201373.","journal-title":"JAMA Surg"},{"issue":"3","key":"16857_CR21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/cpt.2041","volume":"109","author":"O Lee","year":"2021","unstructured":"Lee O, Pilewskie M, Karlan S, Tull MB, Benante K, Xu Y, Blanco L, Helenowski I, Kocherginsky M, Yadav S, Hosseini O, Hansen N, Bethke K, Muzzio M, Troester MA, Dimond E, Perloff M, Heckman-Stoddard B, Khan SA. Local transdermal delivery of telapristone acetate through breast skin, compared with oral treatment: a randomized double-blind, placebo-controlled phase II trial. Clin Pharmacol Ther. 2021;109(3):728\u201338.","journal-title":"Clin Pharmacol Ther"},{"key":"16857_CR22","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1245\/s10434-021-11169-6","volume":"29","author":"EA Verbus","year":"2022","unstructured":"Verbus EA, Khan TM, Hernandez JM, et al. Evaluating the effects of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ. Ann Surg Oncol. 2022;29:2769\u201370.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16857-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16857-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16857-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T17:29:01Z","timestamp":1741195741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16857-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["16857"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16857-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}